TABLE 1.

Baseline demographics and clinical characteristics of study participants

Patient characteristics	Sofosbuvir+Ledipasvir (n=14)
Median age (IQR)	59 (48–70)
Male sex, n (%)	13 (93%)
Median BMI (range), kg/m2	28.5 (19.8–38.4)
Black race, n (%)	13 (93)
Interleukin-28B genotype, n (%)
CC	2 (14)
TT	7 (50)
CT	5 (36)
Histological activity index score fibrosis score, n (%)
0–1	7 (50)
3–4	7 (50)
HCV genotype 1 subtype, n (%)
1a	8 (57)
1b	6 (43)
Median baseline HCV RNA level (range) log10 IU/mL, n (%)	6.31 (5.50–6.76)

BMI, body mass index; GT-1, genotype 1; HCV, hepatitis C virus; IQR, interquartile range.